BC Innovations | Nov 20, 2014
Distillery Therapeutics

Indication: Neurology

Indication Target/marker/pathway Summary Licensing status Publication and contact information Neurology Amyotrophic lateral sclerosis (ALS) Adducin 1 (ADD1); ATPase Na+/K+ transporting a2 polypeptide (ATP1A2) In vitro and mouse studies suggest inhibiting ADD1 or ATP1A2 could help...
Items per page:
1 - 1 of 1